For: | Genova E, Cavion F, Lucafò M, Leo LD, Pelin M, Stocco G, Decorti G. Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events. World J Stem Cells 2019; 11(12): 1020-1044 [PMID: 31875867 DOI: 10.4252/wjsc.v11.i12.1020] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i12/1020.htm |
Number | Citing Articles |
1 |
Ergang Wang, Kun Xiang, Yun Zhang, Xiao-Fan Wang. Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models. Journal of the National Cancer Center 2022; 2(4): 263 doi: 10.1016/j.jncc.2022.10.001
|
2 |
Elena Genova, Gabriele Stocco, Giuliana Decorti. Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis. World Journal of Gastroenterology 2021; 27(35): 5796-5802 doi: 10.3748/wjg.v27.i35.5796
|
3 |
Elahe Eftekhari, Marzieh Ghollasi, Raheleh Halabian, Maryam Soltanyzadeh, Seyed Ehsan Enderami. Nisin and non-essential amino acids: new perspective in differentiation of neural progenitors from human-induced pluripotent stem cells in vitro. Human Cell 2021; 34(4): 1142 doi: 10.1007/s13577-021-00537-9
|
4 |
Lidia Pollara, Virginie Sottile, Enza Maria Valente. Patient-derived cellular models of primary ciliopathies. Journal of Medical Genetics 2022; 59(6): 517 doi: 10.1136/jmedgenet-2021-108315
|
5 |
Colin Rae, Francesco Amato, Chiara Braconi. Patient-Derived Organoids as a Model for Cancer Drug Discovery. International Journal of Molecular Sciences 2021; 22(7): 3483 doi: 10.3390/ijms22073483
|
6 |
Tatiana R. Perry, Michelle L. Roberts, Bipin Sunkara, Ragasnehith Maddula, Tyson McLeish, Jose Gomez, Julliette Lucas, David Rayan, Sahishnu Patel, Mingyu Liang, Zeljko J. Bosnjak, Sherry-Ann Brown. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention. Current Oncology Reports 2021; 23(7) doi: 10.1007/s11912-021-01066-2
|
7 |
Rebecca Marie Dewhurst, Elisa Molinari, John A. Sayer. Spheroids, organoids and kidneys-on-chips: how complex human cellular models have assisted in the study of kidney disease and renal ciliopathies. Microfluidics and Nanofluidics 2023; 27(3) doi: 10.1007/s10404-023-02629-4
|
8 |
Duygu Uçkan-Çetinkaya, Khawaja Husnain Haider. Stammzellen. 2023; : 225 doi: 10.1007/978-3-031-25378-2_13
|
9 |
Marianna Lucafò, Martina Franzin, Giuliana Decorti, Gabriele Stocco. A patent review of anticancer glucocorticoid receptor modulators (2014-present). Expert Opinion on Therapeutic Patents 2020; 30(5): 313 doi: 10.1080/13543776.2020.1740206
|
10 |
Elena Genova, Gabriele Stocco, Giuliana Decorti. Induced Pluripotent Stem Cells to Model Adverse Drug Reactions in Pediatric Patients. Pharmacogenomics 2020; 21(14): 975 doi: 10.2217/pgs-2020-0082
|
11 |
Mikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, Beatriz Martins, Firas Hamdan, Vincenzo Cerullo. Patient-Derived Organoids for Precision Cancer Immunotherapy. Cancer Research 2021; 81(12): 3149 doi: 10.1158/0008-5472.CAN-20-4026
|
12 |
Paola Rispoli, Tatiana Scandiuzzi Piovesan, Giuliana Decorti, Gabriele Stocco, Marianna Lucafò. iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy. WIREs Mechanisms of Disease 2024; 16(1) doi: 10.1002/wsbm.1630
|
13 |
Jia Yao, Man Yang, Lawrence Atteh, Pinyan Liu, Yongcui Mao, Wenbo Meng, Xun Li. A pancreas tumor derived organoid study: from drug screen to precision medicine. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02044-1
|
14 |
Duygu Uçkan-Çetinkaya, Khawaja Husnain Haider. Stem Cells. 2021; : 203 doi: 10.1007/978-3-030-77052-5_13
|